Job postings

COMPANY SUMMARY:Iterion Therapeutics is a venture-backed, clinical stage biotechnology company developing noveltargeted cancer therapeutics. Position Summary:The Vice President, Development and Corporate Strategy is responsible for the overarching product development strategy with responsibility for gathering cross-functional input, synthesizing team recommendations, and directing the overall program prioritization and progress while maintaining adherence

United States, Houston (Texas) Today Lonza is a global leader in life sciences. We are more than 15,000 employees in more than 100 locations around the world. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together,

United States, Houston (Texas) Today Lonza is a global leader in life sciences. We are more than 15,000 employees in more than 100 locations around the world. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together,

Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation for our pipeline of Adoptive Cell Therapies and TCR Bispecifics

Who are we? We are Cancer Insight.  We are a growing CRO that specializes in developing cutting-edge immuno-oncology (IO) drugs.  We specialize in designing and executing early-phase IO trials, yet we also run large, multi-site, adaptive, later-stage trials.  We are specialists in the most exciting field in medicine—immuno-oncology.  Our success

Who are we? We are Cancer Insight.  We are a growing CRO that specializes in developing cutting-edge immuno-oncology (IO) drugs.  We specialize in designing and executing early-phase IO trials, yet we also run large, multi-site, adaptive, later-stage trials.  We are specialists in the most exciting field in medicine—immuno-oncology.  Our success

Who are we? We Are Cancer Insight.  We are a growing CRO that specializes in developing cutting-edge immuno-oncology (IO) drugs.  We specialize in designing and executing early-phase IO trials, yet we also run large, multi-site, adaptive, later-stage trials.  We are specialists in the most exciting field in medicine—immuno-oncology.  Our success